The World Health Organization (WHO) has sounded a global alarm over the rapid rise of antimicrobial resistance (AMR), warning that the world is running out of effective treatments for common infections. In 2023, one in six bacterial infections worldwide showed resistance to antibiotics, compromising life-saving care and turning previously treatable conditions into potential killers. “As antibiotic resistance continues to rise, we’re running out of treatment options and putting lives at risk,” said Dr. Yvan J-F. Hutin, WHO’s head of antimicrobial resistance.
According to WHO’s latest AMR surveillance report, resistance increased in over 40% of the 22 monitored antibiotics between 2018 and 2023, with annual growth rates of 5–15%. Particularly alarming are findings that more than 40% of E. coli and 55% of K. pneumoniae infections are now resistant to third-generation cephalosporins—standard drugs for severe bloodstream infections. Globally, AMR superbugs directly cause over one million deaths each year and contribute to nearly five million more.
While WHO noted improvements in global surveillance, 48% of countries still do not report AMR data, leaving major blind spots. The highest resistance rates were recorded in Southeast Asia and the Eastern Mediterranean, where one in three infections are resistant, followed by Africa, where one in five infections show resistance. WHO Director-General Tedros Adhanom Ghebreyesus warned that antimicrobial resistance is “outpacing advances in modern medicine,” calling for urgent global action to strengthen health systems, surveillance, and responsible antibiotic use before the world faces a future where common infections once again become deadly.
